Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
The development of neuropathic syndromes is an important, dose limiting side effect of anticancer agents like platinum derivates, taxanes and vinca alkaloids. The causes of neurotoxicity are still unclear but the impairment of the oxidative equilibrium is strictly related to pain. Two intracellular...
Guardado en:
Autores principales: | Matteo Zanardelli, Laura Micheli, Lorenzo Cinci, Paola Failli, Carla Ghelardini, Lorenzo Di Cesare Mannelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a83c444a7525400caac9e576ea1d6ed9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Richard Brust, et al.
Publicado: (2018) -
Antioxidant support to ameliorate the oxaliplatin-dependent microglial alteration: morphological and molecular study
por: Jacopo J.V. Branca, et al.
Publicado: (2021) -
Prenatal polycyclic aromatic hydrocarbon, adiposity, peroxisome proliferator-activated receptor (PPAR) γ methylation in offspring, grand-offspring mice.
por: Zhonghai Yan, et al.
Publicado: (2014) -
Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?
por: Juan M Zolezzi, et al.
Publicado: (2013) -
Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel
por: Jeremy Chung Bo Chiang, et al.
Publicado: (2021)